Clinically Approved Antibiotics from 2010 to 2022
DOI:
https://doi.org/10.2533/chimia.2023.230Keywords:
Antibiotics, Antimicrobial resistance, Natural products, Semisynthesis, TuberculosisAbstract
This review discusses small molecule antibiotics approved for clinical use in the time frame 2010-2022. This time span saw the approval of four synthetic antibiotics (bedaquiline, pretomanid, delafloxacin, tedizolid), nine natural product derivatives (ceftaroline fosamil, cefiderocol, plazomicin, omadacycline, eravacycline, sarecycline, lefamulin, dalbavancin, oritavancin), and one natural product (fidaxomicin).
Downloads
Published
2023-04-26
How to Cite
[1]
E. Jung, K. Gademann, Chimia 2023, 77, 230, DOI: 10.2533/chimia.2023.230.
Issue
Section
Scientific Articles
License
Copyright (c) 2023 Erik Jung, Karl Gademann

This work is licensed under a Creative Commons Attribution 4.0 International License.